405 related articles for article (PubMed ID: 27750030)
1. Evaluation of NLRC4, NLRP1, and NLRP3, as Components of Inflammasomes, in Chronic Hepatitis B Virus-Infected Patients.
Askari A; Nosratabadi R; Khaleghinia M; Zainodini N; Kennedy D; Shabani Z; Kazemi Arababadi M
Viral Immunol; 2016 Nov; 29(9):496-501. PubMed ID: 27750030
[TBL] [Abstract][Full Text] [Related]
2. Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis.
Guo Q; Wu Y; Hou Y; Liu Y; Liu T; Zhang H; Fan C; Guan H; Li Y; Shan Z; Teng W
Front Immunol; 2018; 9():1197. PubMed ID: 29915579
[TBL] [Abstract][Full Text] [Related]
3. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
4. Differential Activation of NLRP3, AIM2, and IFI16 Inflammasomes in Humans with Acute and Chronic Hepatitis B.
Chen H; He G; Chen Y; Zhang X; Wu S
Viral Immunol; 2018 Nov; 31(9):639-645. PubMed ID: 30222506
[TBL] [Abstract][Full Text] [Related]
5. NLRP3 inflammasome and related cytokines reflect the immune status of patients with HBV-ACLF.
Jia Y; Ma L; Wang Y; Wang W; Shen C; Wang X; Xu H; Zhao C
Mol Immunol; 2020 Apr; 120():179-186. PubMed ID: 32169738
[TBL] [Abstract][Full Text] [Related]
6. The NLRP1 inflammasomes.
Chavarría-Smith J; Vance RE
Immunol Rev; 2015 May; 265(1):22-34. PubMed ID: 25879281
[TBL] [Abstract][Full Text] [Related]
7. IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.
Zhou Y; Zhang H; Li Y
Cytokine; 2015 May; 73(1):169-75. PubMed ID: 25752977
[TBL] [Abstract][Full Text] [Related]
8. HIV replication is associated to inflammasomes activation, IL-1β, IL-18 and caspase-1 expression in GALT and peripheral blood.
Feria MG; Taborda NA; Hernandez JC; Rugeles MT
PLoS One; 2018; 13(4):e0192845. PubMed ID: 29672590
[TBL] [Abstract][Full Text] [Related]
9. Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.
Shen T; Wu WM; Du WH; Wang L; He G; Tan L; Wang Z; Chen R; Hu M; Ren YP
Lipids Health Dis; 2016 Dec; 15(1):210. PubMed ID: 27927202
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of NOD-like receptor-associated inflammasome activation.
Wen H; Miao EA; Ting JP
Immunity; 2013 Sep; 39(3):432-41. PubMed ID: 24054327
[TBL] [Abstract][Full Text] [Related]
11. Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus.
Yang Q; Yu C; Yang Z; Wei Q; Mu K; Zhang Y; Zhao W; Wang X; Huai W; Han L
J Rheumatol; 2014 Mar; 41(3):444-52. PubMed ID: 24334646
[TBL] [Abstract][Full Text] [Related]
12. Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?
Balkan A; Namiduru M; Balkan Y; Mete AO; Karaoglan I; Bosnak VK
Saudi J Gastroenterol; 2016; 22(3):208-14. PubMed ID: 27184639
[TBL] [Abstract][Full Text] [Related]
13. mRNA expression of glucocorticoid receptor and serological and virological markers of chronic hepatitis B.
Mei B; Chen Y; Liu W; Li L; Wang C
Mol Med Rep; 2015 Mar; 11(3):2215-20. PubMed ID: 25394950
[TBL] [Abstract][Full Text] [Related]
14. The inhibitor effect of RKIP on inflammasome activation and inflammasome-dependent diseases.
Qin Q; Liu H; Shou J; Jiang Y; Yu H; Wang X
Cell Mol Immunol; 2021 Apr; 18(4):992-1004. PubMed ID: 32901127
[TBL] [Abstract][Full Text] [Related]
15. Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke.
Poh L; Kang SW; Baik SH; Ng GYQ; She DT; Balaganapathy P; Dheen ST; Magnus T; Gelderblom M; Sobey CG; Koo EH; Fann DY; Arumugam TV
Brain Behav Immun; 2019 Jan; 75():34-47. PubMed ID: 30195027
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Surface Antigen Quantification across Different Phases of Chronic Hepatitis B Virus Infection Using an Immunoradiometric Assay.
Chung KH; Kim W; Kim BG; Lee HY; Jin E; Cho Y; Seo JY; Kim HY; Jung YJ; Kim JW; Jeong JB; Lee KL
Gut Liver; 2015 Sep; 9(5):657-64. PubMed ID: 25717049
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of TRIF in chronic HBV infected Iranian patients.
Ayoobi F; Hassanshahi G; Zainodini N; Khorramdelazad H; Arababadi MK; Kennedy D
Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):491-5. PubMed ID: 23433963
[TBL] [Abstract][Full Text] [Related]
18. AIM2 and NLRC4-driven inflammasome activation in adult-onset Still's disease and the preliminary therapeutic effect exploration of carboxyamidotriazole.
Duan M; Shen M; Zhou Y; He Y; Guo Z; Ye C; Li J; Zhu L
Clin Rheumatol; 2023 Jun; 42(6):1635-1643. PubMed ID: 36418508
[TBL] [Abstract][Full Text] [Related]
19. Role of serum hepatitis B virus marker quantitation to differentiate natural history phases of HBV infection.
Wang L; Zou ZQ; Wang K; Yu JG; Liu XZ
Hepatol Int; 2016 Jan; 10(1):133-8. PubMed ID: 26427997
[TBL] [Abstract][Full Text] [Related]
20. e-antigen-negative chronic hepatitis B in Bangladesh.
Ahmad N; Alam S; Mustafa G; Adnan AB; Baig RH; Khan M
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):379-82. PubMed ID: 18693173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
